Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Costs and expenses:        
Research and development $ 5,270,967 $ 3,075,830 $ 15,784,546 $ 5,827,109
Selling, general and administrative 5,919,731 1,974,705 11,169,022 4,005,786
Change in fair value contingent consideration (358,420) 0 (1,523,284) 0
Total costs and expenses 10,832,278 5,050,535 25,430,284 9,832,895
Loss from operations (10,832,278) (5,050,535) (25,430,284) (9,832,895)
Interest income 916,755 90,927 1,836,026 223,652
Net loss (9,915,523) (4,959,608) (23,594,258) (9,609,243)
Other comprehensive income (loss), net of tax        
Unrealized gain (loss) on marketable securities (1,977) 776 34,304 (1,901)
Comprehensive loss $ (9,917,500) $ (4,958,832) $ (23,559,954) $ (9,611,144)
Net loss per share - basic $ (0.11) $ (0.66) $ (0.26) $ (1.38)
Net loss per share - diluted $ (0.11) $ (0.66) $ (0.26) $ (1.38)
Weighted-average number of shares outstanding basic 90,009,625 7,535,667 89,774,703 6,939,779
Weighted-average number of shares outstanding diluted 90,009,625 7,535,667 89,774,703 6,939,779